Center Leadership
Aimee Campbell, PhD, MSW
Aimee Campbell, PhD, MSW
Deputy Director, Dissemination & Implementation Core, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth; Associate Professor of Clinical Psychiatric Social Work, Columbia University Irving Medical Center Department of Psychiatry Division on Substance Use Disorders and New York State Psychiatric Institute
Dr. Campbell’s research focuses on the development and testing of individual and program level interventions for substance use disorders, co-occurring mental health disorders, and HIV prevention and treatment, including the leveraging of technology-based platforms, with the objective of increasing adoption and implementation of evidence-based treatments. Dr. Campbell co-led, with Dr. Edward Nunes, one of the largest multi-site randomized controlled trials of a technology based intervention for substance use disorders, resulting in the first FDA clearance of a digital therapeutic. Her current research includes NIDA-funded projects to test an adapted technology-based intervention with American Indian/Alaska Native addiction treatment seekers and to develop and test an implementation intervention to culturally center the delivery of medications for opioid use disorder in partnership with four Tribal communities and a national collaborative board. Since 2017, Dr. Campbell has provided implementation facilitation as part of the SAMHSA-funded Providers’ Clinical Support System (PCSS) and more recently for the Opioid Response Network. She also serves as an Associate Director of Columbia University’s CHOSEN Center (Center for Healing Opioid and Other Substance Use Disorders). Dr. Campbell received her PhD in 2009 from Columbia University School of Social Work.
Selected Publications
- Paschen-Wolff MM, Campbell ANC, Tross S, Choo TH, Pavlicova M, Braunstein S, Lazar R, Borges C, Castro M, Berg H, Harriman G, Remien RH, Des Jarlais D. Durable viral suppression among people with HIV and problem substance use in the era of universal antiretroviral treatment. AIDS Behav. 2022 Feb;26(2):385-396. doi: 10.1007/s10461-021-03392-9. PMID: 34331177; PMCID: PMC8800950. View Source
- Campbell ANC, McCarty D, Rieckmann T, McNeely J, Rotrosen J, Wu LT, Bart G. Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis. J Subst Abuse Treat. 2019 Feb;97:41-46. doi: 10.1016/j.jsat.2018.11.005. PMID: 30577898; PMCID: PMC6310476. View Source
- Campbell ANC, Wolff M, Weaver L, Jarlais DD, Tross S. "It's never just about the HIV:" HIV primary care providers' perception of substance use in the era of "universal" antiretroviral medication treatment. AIDS Behav. 2018;22(3):1006-17. PMID: 29264736; PMCID: PMC5850963. View Source
- Campbell ANC, Montgomery L, Sanchez K, Pavlicova M, Hu M, Newville H, Weaver L, Nunes EV. Racial/ethnic subgroup differences in outcomes and acceptability of an Internet-delivered intervention for substance use disorders. J Ethn Subst Abuse. 2017 Oct-Dec;16(4):460-478. doi: 10.1080/15332640.2017.1300550. PMID: 28368740; PMCID: PMC5624812. View Source
- Campbell AN, Nunes EV, Pavlicova M, Hatch-Maillette M, Hu MC, Bailey GL, Sugarman DE, Miele GM, Rieckmann T, Shores-Wilson K, Turrigiano E, Greenfield SF. Gender-based outcomes and acceptability of a computer-assisted psychosocial intervention for substance use disorders. J Subst Abuse Treat. 2015;53:9-15. PMID: 25613105; PMCID: PMC4414709. View Source
- Campbell AN, Turrigiano E, Moore M, Miele GM, Rieckmann T, Hu MC, Kropp F, Ringor-Carty R, Nunes EV. Acceptability of a web-based community reinforcement approach for substance use disorders with treatment-seeking American Indians/Alaska Natives. Community Ment Health J. 2015;51(4):393-403. PMID: 25022913; PMCID: PMC4295007. View Source
- Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE. Internet-delivered treatment for substance abuse: A multisite randomized controlled trial. Am J Psychiatry. 2014;171(6):683-90. PMID: 24700332. View Source
- Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network. Contemp Clin Trials. 2012;33(2):386-95. PMID: 22085803; PMCID: PMC3268951. View Source